Ningbo Menovo Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002Y25
CNY
20.00
0.13 (0.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,352.49
1,204.62
1,442.39
1,246.66
1,180.47
1,168.96
839.40
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,352.49
1,204.62
1,442.39
1,246.66
1,180.47
1,168.96
839.40
Raw Material Cost
960.76
880.32
921.06
829.51
792.37
753.94
591.94
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
197.02
173.71
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
49.13
29.98
28.06
27.66
27.39
24.65
20.19
Selling and Distribution Expenses
199.15
193.09
221.19
169.03
149.12
164.46
116.09
Other Expenses
4.05
5.47
5.45
4.91
-15.80
-15.05
1.41
Total Expenditure (Excl Depreciation)
1,249.51
1,158.10
1,224.76
1,075.32
1,007.86
966.23
742.33
Operating Profit (PBDIT) excl Other Income
103
46.5
217.60000000000002
171.29999999999998
172.60000000000002
202.7
97.10000000000001
Other Income
23.97
28.25
191.36
32.30
14.38
18.31
48.46
Operating Profit (PBDIT)
244.86
173.78
504.71
306.54
250.56
275.83
191.85
Interest
49.13
29.98
28.06
27.66
27.39
24.65
20.19
Exceptional Items
24.26
-18.33
-6.23
-4.96
70.84
-0.77
-5.95
Gross Profit (PBDT)
391.73
324.30
521.33
417.15
388.10
415.01
247.46
Depreciation
136.73
125.55
109.26
102.63
90.61
64.55
50.93
Profit Before Tax
83.26
-0.08
361.16
171.29
203.40
185.85
114.78
Tax
10.91
-8.22
16.44
22.22
43.27
26.45
1.70
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
66.81
11.59
338.86
142.53
155.96
150.90
96.35
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
66.81
11.59
338.86
142.53
155.96
150.90
96.35
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
9.24
4.60
28.87
15.54
5.69
9.90
8.71
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
76.05
16.18
367.73
158.07
161.65
160.80
105.06
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,192.74
2,096.25
2,084.89
1,751.48
1,564.70
1,364.14
1,197.15
Earnings per share (EPS)
0.31
0.05
1.49
0.66
0.76
0.73
0.47
Diluted Earnings per share
0.31
0.05
1.49
0.66
0.76
0.73
0.47
Operating Profit Margin (Excl OI)
6.22%
1.66%
14.15%
13.76%
12.33%
16.51%
11.02%
Gross Profit Margin
16.27%
10.42%
32.61%
21.97%
24.91%
21.42%
19.74%
PAT Margin
4.94%
0.96%
23.49%
11.43%
13.21%
12.91%
11.48%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 12.28% vs -16.49% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 369.14% vs -95.59% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 51.82% vs -53.57% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 63.67% vs 6.76% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Ningbo Menovo Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,352.49
0
1,352.49
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,352.49
0
1,352.49
Raw Material Cost
960.76
0
960.76
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
49.13
0
49.13
Selling and Distribution Expenses
199.15
0
199.15
Other Expenses
4.05
0.00
4.05
Total Expenditure (Excl Depreciation)
1,249.51
0
1,249.51
Operating Profit (PBDIT) excl Other Income
102.99
0.00
102.99
Other Income
23.97
0
23.97
Operating Profit (PBDIT)
244.86
0
244.86
Interest
49.13
0
49.13
Exceptional Items
24.26
0
24.26
Gross Profit (PBDT)
391.73
0
391.73
Depreciation
136.73
0
136.73
Profit Before Tax
83.26
0
83.26
Tax
10.91
0
10.91
Provisions and contingencies
0
0
0.00
Profit After Tax
66.81
0
66.81
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
66.81
0
66.81
Share in Profit of Associates
0
0
0.00
Minority Interest
9.24
0
9.24
Other related items
0.00
0.00
0.00
Consolidated Net Profit
76.05
0
76.05
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,192.74
0
2,192.74
Earnings per share (EPS)
0.31
0
0.31
Diluted Earnings per share
0.31
0
0.31
Operating Profit Margin (Excl OI)
6.22%
0%
0.00
6.22%
Gross Profit Margin
16.27%
0%
0.00
16.27%
PAT Margin
4.94%
0%
0.00
4.94%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 135.25 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 12.28% vs -16.49% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 7.60 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 369.14% vs -95.59% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.09 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 51.82% vs -53.57% in Dec 2023

Annual - Interest
Interest 4.91 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 63.67% vs 6.76% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.22%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023